Repurposing of cefpodoxime proxetil as potent neuroprotective agent through computational prediction and in vitro validation
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Biomolecular Structure and Dynamics"
DOI: 10.1080/07391102.2020.1772884
Abstract: Abstract In recent reports, NR2B-NMDA receptor antagonists showed more research value because of its strong targeting ability and less side effects potential. In 2016, EVT-101 was reported to bind in an almost entirely new binding… read more here.
Keywords: repurposing cefpodoxime; neuroprotective agent; proxetil potent; cefpodoxime proxetil ... See more keywords